Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Mar 17:10:1162879.
doi: 10.3389/fmolb.2023.1162879. eCollection 2023.

Editorial: Advances in Alzheimer's disease diagnostics, brain delivery systems, and therapeutics

Ashok Iyaswamy  1   2 , Karthick Vasudevan  3 , Selvaraj Jayaraman  4 , Ravindran Jaganathan  5 , Abhimanyu Thakur  6 , Raymond Chuen-Chung Chang  7 , Chuanbin Yang  8
Affiliations
Editorial

Editorial: Advances in Alzheimer's disease diagnostics, brain delivery systems, and therapeutics

Ashok Iyaswamy et al. Front Mol Biosci. .
No abstract available

Keywords: Alzheiemer’s disease; brain delivery systems; diagnostics; neurodegenerative diseases; therapeutics.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
See this image and copyright information in PMC

Comment on

  • Editorial on the Research Topic Advances in Alzheimer’s disease diagnostics,brain delivery systems and therapeutics

References

    1. Cai Q., Jeong Y. Y. (2020). Mitophagy in alzheimer's disease and other age-related neurodegenerative diseases. Cells 9, 150. 10.3390/cells9010150 - DOI - PMC - PubMed
    1. Durairajan S. S. K., Iyaswamy A., Shetty S. G., Kammella A. K., Malampati S., Shang W., et al. (2017). A modified formulation of Huanglian-Jie-Du-Tang reduces memory impairments and beta-amyloid plaques in a triple transgenic mouse model of Alzheimer's disease. Sci. Rep. 7, 6238. 10.1038/s41598-017-06217-9 - DOI - PMC - PubMed
    1. Hansson O. (2021). Biomarkers for neurodegenerative diseases. Nat. Med. 27, 954–963. 10.1038/s41591-021-01382-x - DOI - PubMed
    1. Iyaswamy A., Krishnamoorthi S. K., Liu Y. W., Song J. X., Kammala A. K., Sreenivasmurthy S. G., et al. (2020a). Yuan-hu Zhi Tong prescription mitigates tau pathology and alleviates memory deficiency in the preclinical models of alzheimer's disease. Front. Pharmacol. 11, 584770. 10.3389/fphar.2020.584770 - DOI - PMC - PubMed
    1. Iyaswamy A., Krishnamoorthi S. K., Song J. X., Yang C. B., Kaliyamoorthy V., Zhang H., et al. (2020b). NeuroDefend, a novel Chinese medicine, attenuates amyloid-beta and tau pathology in experimental Alzheimer's disease models. J. Food Drug Anal. 28, 132–146. 10.1016/j.jfda.2019.09.004 - DOI - PubMed

Publication types